TITLE

Extreme Genetic Fragility of the HIV-1 Capsid

AUTHOR(S)
Rihn, Suzannah J.; Wilson, Sam J.; Loman, Nick J.; Alim, Mudathir; Bakker, Saskia E.; Bhella, David; Gifford, Robert J.; Rixon, Frazer J.; Bieniasz, Paul D.
PUB. DATE
June 2013
SOURCE
PLoS Pathogens;Jun2013, Vol. 9 Issue 6, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Genetic robustness, or fragility, is defined as the ability, or lack thereof, of a biological entity to maintain function in the face of mutations. Viruses that replicate via RNA intermediates exhibit high mutation rates, and robustness should be particularly advantageous to them. The capsid (CA) domain of the HIV-1 Gag protein is under strong pressure to conserve functional roles in viral assembly, maturation, uncoating, and nuclear import. However, CA is also under strong immunological pressure to diversify. Therefore, it would be particularly advantageous for CA to evolve genetic robustness. To measure the genetic robustness of HIV-1 CA, we generated a library of single amino acid substitution mutants, encompassing almost half the residues in CA. Strikingly, we found HIV-1 CA to be the most genetically fragile protein that has been analyzed using such an approach, with 70% of mutations yielding replication-defective viruses. Although CA participates in several steps in HIV-1 replication, analysis of conditionally (temperature sensitive) and constitutively non-viable mutants revealed that the biological basis for its genetic fragility was primarily the need to coordinate the accurate and efficient assembly of mature virions. All mutations that exist in naturally occurring HIV-1 subtype B populations at a frequency >3%, and were also present in the mutant library, had fitness levels that were >40% of WT. However, a substantial fraction of mutations with high fitness did not occur in natural populations, suggesting another form of selection pressure limiting variation in vivo. Additionally, known protective CTL epitopes occurred preferentially in domains of the HIV-1 CA that were even more genetically fragile than HIV-1 CA as a whole. The extreme genetic fragility of HIV-1 CA may be one reason why cell-mediated immune responses to Gag correlate with better prognosis in HIV-1 infection, and suggests that CA is a good target for therapy and vaccination strategies.
ACCESSION #
88957112

 

Related Articles

  • Structure of the ESCRT-II endosomal trafficking complex. Hierro, Aitor; Ji Sun; Rusnak, Alexander S.; Kim, Jaewon; Prag, Gali; Emr, Scott D.; Hurley, James H. // Nature;9/9/2004, Vol. 431 Issue 7005, p221 

    The multivesicular-body (MVB) pathway delivers transmembrahe proteins and lipids to the lumen of the endosome. The multivesicular-body sorting pathway has crucial roles in growth-factor-receptor downregulatlon1, developmental signalling2-4, regulation of the immune response5 and the budding of...

  • The S40 residue in HIV-1 Gag p6 impacts local and distal budding determinants, revealing additional late domain activities. Watanabe, Susan M.; Min-Huei Chen; Khan, Mahfuz; Ehrlich, Lorna; Kemal, Kimdar Sherefa; Weiser, Barbara; Binshan Shi; Chaoping Chen; Powell, Michael; Anastos, Kathryn; Burger, Harold; Carter, Carol A. // Retrovirology;2013, Vol. 10 Issue 1, p1 

    Background HIV-1 budding is directed primarily by two motifs in Gag p6 designated as late domain-1 and -2 that recruit ESCRT machinery by binding Tsg101 and Alix, respectively, and by poorly characterized determinants in the capsid (CA) domain. Here, we report that a conserved Gag p6 residue,...

  • MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Fricke, Thomas; White, Tommy; Schulte, Bianca; de Souza Aranha Vieira, Daniel; Dharan, Adarsh; Campbell, Edward; Brandariz-Nuñez, Alberto; Diaz-Griffero, Felipe // Retrovirology;2014, Vol. 11 Issue 1, p1 

    Background The IFN-α-inducible restriction factor MxB blocks HIV-1 infection after reverse transcription but prior to integration. Genetic evidence suggested that capsid is the viral determinant for restriction by MxB. This work explores the ability of MxB to bind to the HIV-1 core, and the...

  • Broad neutralizing antibody response and genetic variation in HIV-1 env genes in Koreans with primary HIV-1 infections. Shin, Bo; Kim, Sung; Kim, Gab // Archives of Virology;Mar2011, Vol. 156 Issue 3, p465 

    To determine the neutralization profiles induced by HIV-1 Korean clade B, which has a monophyletic lineage and relative limited genetic diversity, we investigated the ability of HIV variants to elicit neutralizing antibodies in the immune response to primary infection. We selected seven Korean...

  • The Evolutionary Adaptation of HIV-1 to Specific Immunity. da Silva, Jack // Current HIV Research;Jul2003, Vol. 1 Issue 3, p363 

    Recent evidence of the evolutionary adaptation of HIV-1 to the specific immune system is reviewed. Longitudinal studies of patients show that a neutralizing antibody (NAb) response specific to autologous virus is detectable within 1-2 months of infection and that viral variants resistant to...

  • Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis. Simpson, D.; Noble, S.; Perry, C.; Simpson, Dene; Noble, Stuart; Perry, Caroline // CNS Drugs;2002, Vol. 16 Issue 12, p825 

    Unlabelled: Glatiramer acetate is a synthetic copolymer composed of a random mixture of four amino acids that modifies the immune response that results in the CNS inflammation, demyelination and axonal loss characteristic of relapsing-remitting multiple sclerosis (RRMS). In three...

  • Immunoregulatory Effects of L-Arginine and Therapeutical Implications. Potenza, M.A.; Nacci, C.; Mitolo-Chieppa, D. // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;May2001, Vol. 1 Issue 1, p67 

    Arginine, initially classified as a non-essential amino acid, participates to multiple biological processes including release of several hormones, collagen synthesis during wound healing, antitumor and antibacterial activities and non-specific immunity. Nitric oxide synthase and arginase...

  • Binding of the Drosophila cytokine Spätzle to Toll is direct and establishes signaling. Weber, Alexander N. R.; Tauszig-Delamasure, Servane; Hoffmann, Jules A.; Lelièvre, Eric; Gascan, Hugues; Ray, Keith P.; Morse, Mary A.; Imler, Jean-Luc; Gay, Nicholas J. // Nature Immunology;Aug2003, Vol. 4 Issue 8, p794 

    The extracellular protein Spätzle is required for activation of the Toll signaling pathway in the embryonic development and innate immune defense of Drosophila. Spätzle is synthesized as a pro-protein and is processed to a functional form by a serine protease. We show here that the mature...

  • In Shape - The Art of Mapping Conformational Epitopes. Gadermaier, Elisabeth // International Archives of Allergy & Immunology;Mar2012, Vol. 157 Issue 4, p321 

    No abstract available Copyright © 2010 S. Karger AG, Basel

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics